Laura Gibson is an associate professor of medicine and of pediatrics at UMass Chan Medical School. CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in ...

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...

Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of ...

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven ...

—These investigators explored associations among early-life and in utero infections and cytomegalovirus-positive acute lymphoblastic leukemia in children, with signs pointing to underlying immune ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

Administering hyperimmune globulin to pregnant women who tested positive for cytomegalovirus (CMV) did not reduce CMV infections or deaths among their fetuses or newborns, according to a randomized ...

Mothers with intrauterine transmission of human cytomegalovirus (CMV) to their newborns despite preconception immunity had higher levels of neutralizing antibodies but had weaker antibody-dependent ...

Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child 14.12.2021 / 07:00 The issuer is solely ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

Moderna said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can ...

PHOENIX – Long before the coronavirus pandemic, Kathleen Muldoon knew what it felt like to have her life changed by a virus. In 2013, Muldoon was teaching embryology at the Geisel School of Medicine ...